ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 152 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2016 | $2,755,000 | +12.5% | 93,781 | +28.1% | 0.01% | +25.0% |
Q4 2015 | $2,449,000 | -12.8% | 73,229 | -5.7% | 0.00% | -20.0% |
Q3 2015 | $2,807,000 | -10.3% | 77,653 | +11.6% | 0.01% | 0.0% |
Q2 2015 | $3,130,000 | +781.7% | 69,565 | +500.4% | 0.01% | +400.0% |
Q1 2015 | $355,000 | -86.4% | 11,586 | -77.3% | 0.00% | -80.0% |
Q4 2014 | $2,612,000 | +45.3% | 51,099 | +12.5% | 0.01% | +66.7% |
Q3 2014 | $1,798,000 | +1.6% | 45,437 | -3.4% | 0.00% | 0.0% |
Q2 2014 | $1,770,000 | +11.0% | 47,033 | +10.4% | 0.00% | 0.0% |
Q1 2014 | $1,594,000 | +8.4% | 42,606 | +6.1% | 0.00% | 0.0% |
Q4 2013 | $1,471,000 | – | 40,146 | +200630.0% | 0.00% | – |
Q3 2013 | $0 | – | 20 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |